SE7408255L - - Google Patents

Info

Publication number
SE7408255L
SE7408255L SE7408255A SE7408255A SE7408255L SE 7408255 L SE7408255 L SE 7408255L SE 7408255 A SE7408255 A SE 7408255A SE 7408255 A SE7408255 A SE 7408255A SE 7408255 L SE7408255 L SE 7408255L
Authority
SE
Sweden
Prior art keywords
formula
hydrogen atom
group
compounds
compound
Prior art date
Application number
SE7408255A
Other versions
SE424865B (en
Inventor
C Lespagnol
D Lesieur
J-P Bonte
Original Assignee
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med filed Critical Inst Nat Sante Rech Med
Publication of SE7408255L publication Critical patent/SE7408255L/xx
Publication of SE424865B publication Critical patent/SE424865B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

1425429 Benzoxazolinone derivatives INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 24 June 1974 [26 June 1973] 27952/74 Heading C2C Novel compounds have the Formula I: m which R 1 represents a hydrogen atom, an unsubstituted or substituted alkyl group containing 1 to 6 carbon atoms, an unsubstituted or substituted phenyl or benzyl group or a thienyl group, R 2 represents a hydrogen atom or an alkyl group containing 1 to 6 carbon atoms, and X represents a hydrogen atom and Y represents a hydroxy group or X and Y together represent an oxo group. The compounds of Formula I in which R 1 is other than a hydrogen atom are obtained by reacting in the presence of polyphosphoric acid a compound of Formula II: with an acid of formula R 1 COOH or a functional derivative thereof (e.g. anhydride or chloride) to form a compound of Formula I wherein X and Y together represent an oxo-group, the corresponding alcohol of Formula I being obtained therefrom by reduction (e.g. NaBH 4 ). The compounds of Formula I wherein R 1 represents a hydrogen atom are prepared by reacting in the presence of polyphosphoric acid a compound of Formula II with hexamethylenetetramine to form the 6-formyl benzoxazolinone derivative of Formula I, the corresponding hydroxymethyl derivative being again obtained by reduction. The examples prepare compounds of Formula I in which R 1 is -CH 3 , -C 2 H 5 , -CH 2 Cl, -C 6 H 5 , -CH 2 C 6 H 5 , thienyl and hydrogen and R 2 is hydrogen or -CH 3 .
SE7408255A 1973-06-26 1974-06-24 BENSOXAZOLINONDERIVAT SE424865B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7323280A FR2244506B1 (en) 1973-06-26 1973-06-26

Publications (2)

Publication Number Publication Date
SE7408255L true SE7408255L (en) 1974-12-27
SE424865B SE424865B (en) 1982-08-16

Family

ID=9121568

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7408255A SE424865B (en) 1973-06-26 1974-06-24 BENSOXAZOLINONDERIVAT

Country Status (13)

Country Link
JP (1) JPS5922711B2 (en)
BE (1) BE816820A (en)
CA (1) CA1019749A (en)
CH (2) CH592642A5 (en)
DE (1) DE2429562A1 (en)
DK (1) DK341274A (en)
FR (1) FR2244506B1 (en)
GB (1) GB1425429A (en)
IL (1) IL45113A (en)
LU (1) LU70403A1 (en)
NL (1) NL179135C (en)
NO (1) NO143531C (en)
SE (1) SE424865B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3039929A1 (en) * 1980-10-23 1982-06-03 Bayer Ag, 5090 Leverkusen ISOCYANATO-OXAZOLINONE, A METHOD FOR THE PRODUCTION OF PLASTIC PRECOWERS HAVING OXAZOLIN-2-ONE RINGS AND THE USE THEREOF FOR THE PRODUCTION OF HIGH-MOLECULAR PLASTICS
DE3042481A1 (en) * 1980-11-11 1982-06-16 A. Nattermann & Cie GmbH, 5000 Köln (OMEGA) - (2-OXO-BENZAZOLINYL) -ALKANIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
GB8325370D0 (en) * 1983-09-22 1983-10-26 Fujisawa Pharmaceutical Co Benzoxazoline and benzothiazoline derivatives
FR2645149A1 (en) * 1989-03-30 1990-10-05 Adir
FR2646350B1 (en) * 1989-04-28 1991-06-28 Adir NOVEL BENZOTHIAZOLINON DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5166353A (en) * 1989-04-28 1992-11-24 Adir Et Compagnie Benzothiazolinone compounds
FR2663634B1 (en) * 1990-06-22 1992-09-04 Adir NOVEL ACYL BENZOXAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2663633B1 (en) * 1990-06-22 1994-06-17 Adir NEW CHALCONES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2756825B1 (en) * 1996-12-10 1999-01-08 Adir NOVEL [3H] -BENZOXAZOLE-2-THIONES AND [3H] - BENZOTHIAZOLE-2-THIONES DERIVATIVES, THEIR PREPARATION METHOD AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR019678A1 (en) * 1998-06-18 2002-03-13 Novartis Ag ORGANIC COMPOUNDS
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
BRPI0917394A2 (en) * 2008-08-18 2019-09-24 Univ Yale mif modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050526A (en) * 1960-08-08 1962-08-21 Rohm & Haas 3-thiocyanomethyl-2-benzothiazolinones and benzoxazolinones

Also Published As

Publication number Publication date
CA1019749A (en) 1977-10-25
DK341274A (en) 1975-02-24
JPS5069073A (en) 1975-06-09
JPS5922711B2 (en) 1984-05-28
BE816820A (en) 1974-12-27
FR2244506A1 (en) 1975-04-18
NL179135C (en) 1986-07-16
CH592642A5 (en) 1977-10-31
NO143531B (en) 1980-11-24
GB1425429A (en) 1976-02-18
FR2244506B1 (en) 1977-02-25
NO143531C (en) 1981-03-11
NL7408489A (en) 1974-12-30
NO742310L (en) 1975-01-20
NL179135B (en) 1986-02-17
IL45113A (en) 1977-06-30
LU70403A1 (en) 1975-03-27
SE424865B (en) 1982-08-16
DE2429562A1 (en) 1975-01-16
CH602679A5 (en) 1978-07-31
IL45113A0 (en) 1974-09-10

Similar Documents

Publication Publication Date Title
GB1425429A (en) Benzoxazolinone derivatives
GB1418822A (en) Imidazo-and pyrimido-2,1-b-quinazolin-2-ones and a process for the preparation thereof
GB1212090A (en) Aliphatic diol-diones
GB1512420A (en) Cyclopropane-1-carboxylic acid derivatives for use as intermediates in the preparation of insecticides
IE812057L (en) Preparing alpha aromatic alkanoic acid derivatives
KR830010039A (en) Method for preparing phenyl fatty carboxylic acid derivative
KR840005122A (en) Method for preparing methyl flavone derivatives
GB1496491A (en) Dihydroergopeptine derivatives
GB1472131A (en) Alkyl derivatives of prostanoic acids and preparation thereof
GB1360164A (en) 3,5-dialkyl-4-hydroxyphenylalkanoic acid esters of hydroxyalkyl hydroxyalkanoates
GB1501476A (en) Process for the preparation of reactive penicillanic acid and cephalosporanic acid derivatives and a process for the preparation thereof
ES416971A1 (en) Fused-ring isoquinoline derivatives
SE7408868L (en)
GB1512272A (en) Thiophene derivatives and process for their manufacture
CH609682A5 (en) Process for the preparation of compounds analogous to prostaglandins
GB1429697A (en) Method for producing isonitrosomalonic esters
GB1379874A (en) Process for the preparation of cyclopentenes
ES428047A1 (en) 4,5,10,13 prostatetraenoic acid derivatives
GB1471856A (en) Cyclohexene derivatives
GB1459949A (en) Penicillin compounds their production and their medicinal use
GB2001974A (en) Vincinic acid derivatives and process for the preparation thereof
GB1302494A (en)
ES467237A1 (en) Derivatives of cyclopropane
GB1422722A (en) Acrylic acid derivatives
KR830008677A (en) Sickle cell therapy, preparation method and composition

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7408255-3

Effective date: 19880318

Format of ref document f/p: F